U
University of California, San Diego | UCSD NAFLD Research Center
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Semaglutide
Parent organization
This site is a part of University of California, San Diego
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 2 total trials
This study is being done to see if a combination of 2 medicines (called NNC0194-0499 and semaglutide) can reduce liver damage in patients with non al...
Active, not recruiting
Non-alcoholic Steatohepatitis
Drug: Placebo (NNC0194-0499)
Drug: NNC0174 0833 placebo
Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabe...
Enrolling
Non-alcoholic Steatohepatitis
Drug: Placebo
Drug: Semaglutide
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems